Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | STING1 | Q86WV6 | 1/20 | 0.33 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.32 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.32 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.32 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.32 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.32 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.32 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.32 |
| ▸ | NR1D1 | P20393 | 1/20 | 0.30 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17521944 | 0.93 | ALDH1A1 (0.31) | ALDH1A1L3MBTL1STING1 | |
| SCHEMBL4565384 | 0.93 | MEN1 (0.34) | ALDH1A1L3MBTL1STING1 | |
| SCHEMBL16100071 | 0.93 | MEN1 (0.34) | ALDH1A1L3MBTL1STING1 | |
| SCHEMBL12348353 | 0.91 | ALDH1A1 (0.31) | ALDH1A1L3MBTL1 | |
| SCHEMBL14754893 | 0.90 | ALDH1A1 (0.30) | ALDH1A1 | |
| SCHEMBL6712289 | 0.88 | ALDH1A1 (0.32) | ALDH1A1L3MBTL1 | |
| SCHEMBL12250920 | 0.87 | — | — | |
| SCHEMBL15000849 | 0.85 | HDAC3 (0.31) | HDAC3HDAC1HDAC2HDAC8HDAC6 | |
| SCHEMBL24570975 | 0.85 | ALDH1A1 (0.46) | ALDH1A1L3MBTL1STING1HDAC3HDAC1 | |
| SCHEMBL16334088 | 0.85 | ALDH1A1 (0.33) | ALDH1A1L3MBTL1STING1HDAC3HDAC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11254786-B2 | Multifunctional degradable nanoparticles with control over size and functionalities | VANDERBILT UNIVERSITY (US) | 2022-02-22 | — | — | US | disclosed |
| CN-111302962-A | Rapid method for reducing nitro in aliphatic nitro compound into amino | 深圳市燃气集团股份有限公司 | 2020-06-19 | — | — | CN | disclosed |
| US-10442890-B2 | Multifunctional degradable nanoparticles with control over size and functionalities | VANDERBILT UNIVERSITY (US) | 2019-10-15 | — | — | US | disclosed |
| US-20180142061-A1 | Multifunctional Degradable Nanoparticles with Control over Size and Functionalities | UNIV VANDERBILT (US) | 2018-05-24 | — | — | US | disclosed |
| US-20180142061-A1 | Multifunctional Degradable Nanoparticles with Control over Size and Functionalities | UNIV VANDERBILT (US) | 2018-05-24 | — | — | US | disclosed |
| US-9919055-B2 | Sugar-linker-drug conjugates | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2018-03-20 | — | — | US | disclosed |
| US-9919055-B2 | Sugar-linker-drug conjugates | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) | 2018-03-20 | — | — | US | disclosed |
| US-9856348-B2 | Multifunctional degradable nanoparticles with control over size and functionalities | VANDERBILT UNIVERSITY (US) | 2018-01-02 | — | — | US | disclosed |
| US-20170313656-A1 | Branched Discrete PEG Constructs | QUANTA BIODESIGN, LTD. | 2017-11-02 | — | — | US | disclosed |
| EP-2637705-B1 | CONJUGATES AND THEIR USES IN MOLECULAR IMAGING | KING S COLLEGE LONDON (GB) | 2017-03-29 | — | — | EP | disclosed |
| US-20080221043-A1 | Guanidinium compounds for drug delivery | VANDERBILT UNIVERSITY | 2008-09-11 | — | — | US | disclosed |
| US-20080221043-A1 | Guanidinium compounds for drug delivery | VANDERBILT UNIVERSITY | 2008-09-11 | — | — | US | disclosed |
| WO-2008024435-A2 | DENDRITIC MOLECULAR INTRACELLULAR TRANSPORTERS AND METHODS OF MAKING AND USING SAME | VANDERBILT UNIVERSITY (US) | 2008-02-28 | — | — | WO | disclosed |
| US-20070142663-A1 | T-butyl cascade polymers | THE UNIVERSITY OF SOUTH FLORIDA | 2007-06-21 | — | — | US | disclosed |
| US-20070142663-A1 | T-butyl cascade polymers | THE UNIVERSITY OF SOUTH FLORIDA | 2007-06-21 | — | — | US | disclosed |
| US-7183426-B2 | T-butyl cascade polymers | NEWKOME GEORGE R | 2007-02-27 | — | — | US | disclosed |
| US-7183426-B2 | T-butyl cascade polymers | NEWKOME GEORGE R | 2007-02-27 | — | — | US | disclosed |
| EP-0638060-A4 | T-BUTYL CASCADE POLYMERS. | UNIV SOUTH FLORIDA (US) | 1995-04-19 | — | — | EP | disclosed |
| EP-0638060-A1 | T-BUTYL CASCADE POLYMERS | UNIVERSITY OF SOUTH FLORIDA (US) | 1995-02-15 | — | — | EP | disclosed |
| WO-1993021144-A1 | T-BUTYL CASCADE POLYMERS | UNIVERSITY OF SOUTH FLORIDA (US) | 1993-10-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11254786-B2 | Multifunctional degradable nanoparticles with control over size and functionalities | DSTN, PARN, CTSA | ALDH1A1 1776/4885L3MBTL1 2435/4885STING1 2150/4885 |
| US-20170313656-A1 | Branched Discrete PEG Constructs | BTD, IDUA, DNPEP | ALDH1A1 939/4885L3MBTL1 567/4885STING1 2568/4885 |
| US-10442890-B2 | Multifunctional degradable nanoparticles with control over size and functionalities | DSTN, PARN, CTSA | ALDH1A1 1776/4885L3MBTL1 2435/4885STING1 2150/4885 |
| US-20080221043-A1 | Guanidinium compounds for drug delivery | GMPS, GUCY1A1, GUCY1A2 | ALDH1A1 2084/4885L3MBTL1 1458/4885STING1 530/4885 |
| US-20180142061-A1 | Multifunctional Degradable Nanoparticles with Control over Size and Functionalities | DSTN, PARN, CTSA | ALDH1A1 1776/4885L3MBTL1 2435/4885STING1 2150/4885 |
| US-20070142663-A1 | T-butyl cascade polymers | TNK1, TST, TNNI3K | ALDH1A1 3616/4885L3MBTL1 2645/4885STING1 2490/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.